Release Date: 12/12/11 13:55 Summary: Initial Director's Interest Notice - P Armstrong Price Sensitive: No Download Document 274.34KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%